Safety and Efficiency of γδ T Cell Against Lung Cancer

NCT03183232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

PROCEDURE: Cryosurgery or IRE surgery
BIOLOGICAL: γδ T cell
OTHER: γδ T cells/ A Cryosurgery or IRE

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]